Rheb is a Critical Regulator of Autophagy During Myocardial Ischemia

Abstract

Background Rheb is a GTP-binding protein that promotes cell survival and mediates the cellular response to energy deprivation (ED). The role of Rheb in the regulation of cell survival during ED has not been investigated in the heart. Methods and Results Rheb is inactivated during cardiomyocyte (CM) glucose deprivation (GD) in vitro, and during acute myocardial ischemia in vivo. Rheb inhibition causes mTORC1 inhibition, because forced activation of Rheb, through Rheb overexpression in vitro and through inducible cardiac-specific Rheb overexpression in vivo, restored mTORC1 activity. Restoration of mTORC1 activity reduced CM survival during GD and increased infarct size after ischemia, both of which were accompanied by inhibition of autophagy, whereas Rheb knockdown increased autophagy and CM survival. Rheb inhibits autophagy mostly through Atg7 depletion. Restoration of autophagy, through Atg7 re-expression and inhibition of mTORC1, increased cellular ATP content and reduced endoplasmic reticulum stress, thereby reducing CM death induced by Rheb activation. Mice with high fat diet-induced obesity and metabolic syndrome (HFD mice) exhibited deregulated cardiac activation of Rheb and mTORC1, particularly during ischemia. HFD mice presented inhibition of cardiac autophagy and displayed increased ischemic injury. Pharmacological and genetic inhibition of mTORC1 restored autophagy and abrogated the increase in infarct size observed in HFD mice, but they failed to protect HFD mice in the presence of genetic disruption of autophagy. Conclusions Inactivation of Rheb protects CMs during ED through activation of autophagy. Rheb and mTORC1 may represent therapeutic targets to reduce myocardial damage during ischemia, particularly in obese patients.

Lipid-induced NOX2 activation inhibits autophagic flux by impairing lysosomal enzyme activity

“…Derangement of autophagy was observed in multiple cardiac pathologies including ischemic and hypertensive heart disease and heart failure ( 12 ). Altered cardiac autophagy has been reported in genetic and dietary models of obesity, suggesting that autophagy might be modulated by increased myocardial lipid uptake or utilization (13)(14)(15). However, the regulation of cardiac autophagy in response to lipid overload is incompletely understood.…”

How to be young at heart? miR-22 as a potential therapeutic target to boost autophagy and protect the old myocardium

“…Autophagy is downregulated in the heart during aging, and downregulation of autophagy plays a causative role in the progression of aging in the heart (2,4). Furthermore, we and others have shown that downregulation of autophagy during pressure overload (5,6), post-myocardial infarction cardiac remodeling (7) and metabolic syndrome (8,9) contributes to the progression of cardiac dysfunction and ischemic injury. On the other hand, excessive activation of autophagy during the acute phase of myocardial infarction or ischemia/reperfusion may be detrimental (10).…”

The Impact of Autophagy on Cardiovascular Senescence and Diseases

“…72) Recent studies have demonstrated that autophagic flux (the maturation process that turns autophagosomes into autolysosomes) is inhibited in diabetic cardiomyopathy. [73][74][75] In diabetes, autophagy helps maintain normal cellular architecture and function. Activation of AMPK by metformin in diabetic mice retrieves cardiac autophagy, protecting cardiac apoptosis with Beclin1 activation by disrupting the Beclin1-Bcl2 complex, which is the inhibited form of Beclin1.…”